Medicure (MCUJF) Retained Earnings (2009 - 2026)
Medicure's (MCUJF) quarterly Retained Earnings came in at -$3.7 million in Q1 2026, down 22.25% year-on-year from -$4.7 million in Q1 2025, and up 1.48% quarter-over-quarter from -$3.7 million in Q4 2025.
Medicure (MCUJF) Retained Earnings (2009 - 2026) Analysis & Trends
Medicure's Retained Earnings history runs 18 years deep, the most recent figure standing at -$3.7 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 22.25% year-over-year to -$3.7 million in Q1 2026; TTM through Mar 2026 was -$3.7 million, a 22.25% decrease from a year earlier, with the FY2025 full-year figure at -$3.7 million, down 18.86% from the prior year.
- Retained Earnings climbed to -$3.7 million in Q1 2026 per MCUJF's latest filing, from -$3.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$3.0 million in Q1 2025 and bottomed at -$5.4 million in Q1 2022.
- The 5-year median for Retained Earnings is -$3.9 million (2022), against an average of -$4.0 million.
- Across the five-year window, Retained Earnings surged 30.61% in 2024 and decreased 22.25% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$4.0 million in 2022, then decreased by 9.41% to -$4.4 million in 2023, then surged by 30.61% to -$3.1 million in 2024, then slipped by 21.5% to -$3.7 million in 2025, then increased by 1.48% to -$3.7 million in 2026.
- Per Business Quant, the three latest MCUJF Retained Earnings figures stand at -$3.7 million (Q1 2026), -$3.7 million (Q4 2025), and -$3.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.65 Mn |
| Dec 31, 2025 | -3.71 Mn |
| Sep 30, 2025 | -3.60 Mn |
| Jun 30, 2025 | -3.84 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | -3.05 Mn |
| Sep 30, 2024 | -4.08 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -4.07 Mn |
| Dec 31, 2023 | -4.40 Mn |
| Sep 30, 2023 | -4.10 Mn |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -4.02 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.95 Mn |
| Mar 31, 2022 | -5.38 Mn |
| Dec 31, 2021 | -5.27 Mn |
| Sep 30, 2021 | -4.88 Mn |
| Jun 30, 2021 | -5.56 Mn |
| Mar 31, 2021 | -5.32 Mn |